“Using Regression Trees to Predict the Development of Immune-Mediated Adverse Events in Patients Receiving Immune Checkpoint Inhibitor Therapy”. Voprosy Onkologii, vol. 70, no. 4, Sept. 2024, pp. 677-84, https://doi.org/10.37469/0507-3758-2024-70-4-677-684.